Otrivine Junior Sine Conservans Tegen Neusverstopping (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Otrivine Junior Sine Conservans Tegen Neusverstopping, is a topical nasal decongestant presented as a nasal spray for nasal use. It relieves nasal congestion and obstruction in children.

GNH USA supplies Otrivine Junior Sine Conservans Tegen Neusverstopping as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride is used as a topical nasal decongestant to alleviate conditions affecting the nasal airway.

Nasal congestion: Reduces swelling of nasal mucosa to improve airflow. Nasal obstruction: Relieves blockage caused by inflammation or viral upper‑respiratory infections. Rhinitis: Alleviates nasal passage swelling associated with allergic or non‑allergic rhinitis.

Xylometazoline Hydrochloride may cause local and systemic adverse reactions, which are categorized by frequency.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing - Altered taste sensation - Mild headache - Transient epistaxis

Serious or Rare Side Effects: - Severe nosebleeds - Allergic reactions such as rash, itching or swelling - Nasal ulceration or perforation - Paradoxical worsening of congestion (rebound congestion) - Anaphylaxis

When using Otrivine Junior, several precautions should be observed to ensure safety and effectiveness.

Duration of use: Limit to no more than three consecutive days to avoid rebound congestion. Age restriction: Use only in children as directed by a healthcare professional. Pre‑existing conditions: Caution in patients with hypertension, cardiovascular disease, hyperthyroidism, or diabetes. Concurrent nasal sprays: Avoid using other topical decongestants simultaneously. Pregnancy and lactation: Use only if clearly needed and prescribed. Store at room temperature: Keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Xylometazoline Hydrochloride can interact with other medicines; awareness of major and moderate interactions helps prevent adverse events.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): May increase hypertensive response. - Other nasal decongestants: Risk of additive vasoconstriction and rebound congestion. - Systemic sympathomimetics (e.g., pseudoephedrine): Potential for excessive cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: May reduce efficacy of blood pressure control. - Beta‑blockers: May blunt cardiovascular effects. - Tricyclic antidepressants: Possible additive sympathomimetic effects.